Archives

by in
Entry Author Date Location
Alnylam RNAi Drug Holds Up After Year of Treatment in Small Study 04/21/15 Boston
Hunting for an IPO? Voyager Gets $60M From “Crossover” Backers 04/13/15 Boston
Gene Therapy’s Rebirth Continues With Bristol, UniQure Cardio Deal 04/06/15 New York
Academia vs. BioPharma: Young Scientists Between A Rock and A Hard Place 04/06/15 Seattle
ImmunoGen Surges on $440M Takeda Deal For “Smart Bomb” Cancer Drugs 03/23/15 Boston
East Coast Biotech Roundup: Sync Project, Epizyme, Bristol & More 03/16/15 Boston
GE Backs Evidation Health to Tackle Digital Health 03/05/15 San Francisco
Tricida Grabs $30M Series B for Chronic Kidney Disease Treatment 03/04/15 San Francisco
Ex-Alnylam Exec to Steer Warp Drive Bio; Verdine Shifts Roles 03/04/15 Boston
As New Sanofi CEO Starts, Viehbacher’s Biotech Fingerprints Abound 02/19/15 Boston
East Coast Biotech Roundup: Genzyme, 21st Century Cures, Acorda, & More 02/13/15 Boston
Gilead Exec: More Value in Quick Hep C Cure than Cancer Treatments 02/10/15 San Francisco
East Coast Biotech Roundup: Hamburg, Merck, Annovation, WaVe & More 02/09/15 Boston
West Coast Biotech Roundup: Tracon, Mirati, Third Rock, & Dendreon 02/06/15 San Diego
Built for a Deal, Annovation Rewards Backers With Medicines Co. Buyout 02/04/15 Boston
East Coast Biotech Roundup: Yumanity, Biogen, Blizzards, & More 01/30/15 Boston
Alnylam CEO: More Cash in Hand Is to Fuel Expansion From Within 01/21/15 Boston
It Had to be You: Why Roche Was The Lone Suitor For Foundation 01/16/15 Boston
Genentech Redux? Roche Buys Majority Stake in Foundation Medicine 01/12/15 Boston
Raleigh-Durham Roundup: BioCryst, Scioderm, Red Hat & More 12/22/14 Raleigh Durham
Prescription Drug Pricing: The Fine Line Between Value and Greed 12/02/14 Boston
Pozen, Sanofi Terminate Drug Pact Ahead of FDA Approval Decision 12/01/14 Raleigh Durham
East Coast Biotech Roundup: Agios, Vertex, Epizyme, Celldex, & More 11/21/14 Boston
With Gilead’s $125M Purchase, FDA Voucher Program Gains Momentum 11/19/14 San Francisco
New Research Could (Finally) Remove RNAi’s Commercial Limitations 11/17/14 National
Deltanoid and Beyond: Madison Legend DeLuca Has More “D” To Play 11/17/14 Wisconsin
East Coast Biotech Roundup: Regeneron, Sage, Tara, Alnylam, & More 11/14/14 Boston
West Coast Biotech Roundup: Intarcia, Dendreon, Amgen, Doudna & More 11/13/14 San Francisco
Struggling Aegerion Diversifies With Fat Disease Drug 11/06/14 Boston
Proteostasis, Astellas Join up on Genetic Disease Drugs 11/04/14 Boston
Page 1 of 6 next page »